Hypertension most common NCD in PLHIV

HYPERTENSION is more prevalent a Non Communicable Disease in People Living With HIV on Antiretroviral Treatment (ART), a study found.
The study seeking to find the incidence of NCDs in PLHIV sought to determine the incidence of NCDs in HIV patients on ART at the Chitungwiza Central Hospital (CCH) over ten years from 2010 to 2019 and the associated risk factors.
The research was done by Alexander Cheza, Boikhutso Tlou and Danai Tavonga Zhou.
The study considered the 500 records in the CCH Opportunistic Infections Clinic register in 2010.
“Data collected at the study’s baseline (2010) showed that the most prevalent NCD was hypertension, found in (18/203) 8.9% of the study participants, followed by diabetes (6.9%), then followed by cardiovascular diseases (CVD) (3.9%), and the least common NCD was cancer (1.9%),” read their findings.
The researchers said, “Incidences of all of these NCDs showed an increasing trend as the time of follow-up progressed. The factors found to be significantly associated with the development of NCDs were gender and follow-up time. “Geographical location was a significant risk factor as urban patients were more likely to develop hypertension as compared to the peri-urban patients.”

“The incidence of non-communicable diseases (NCDs) has been reported to be rising over the years leading up to 2010. In Zimbabwe, there are few studies done to examine the incidence of NCDs in people living with HIV (PLHIV) on anti-retroviral treatment (ART),” said the researchers.

The researchers noted that NCDs and HIV comorbidity is common with women more likely than males to develop NCDs as they advance in age.
“There is need to devise targeted intervention approach to the respective NCDs and risk factors since they affect differently in relation to the demographic details of the participants,” the researchers recommended.
The research was published in May and can be accessed on this website.

Leave a Reply

Your email address will not be published. Required fields are marked *

0 Comments
scroll to top